Concepedia

Matthew A. Boehm

MA

6

Publications

591

Citations

6

H-Index

2016

Active since

Affiliations

National Institute on Drug Abuse(Current)

Johns Hopkins Medicine

National Institutes of Health

National Center for Advancing Translational Sciences

Johns Hopkins University

Matthew A. Boehm is an author at National Institute on Drug Abuse specializing in substance abuse, pharmacotherapy, and neuropharmacology.

ORCID

Top concepts

Publications per year

2016–2023

6

Publications

6

Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

Jordi Bonaventura, Sherry Lam, Meghan L. Carlton et al. · Molecular Psychiatry · 2021 · 246 citations · Full text

, , +11

High-potency ligands for DREADD imaging and activation in rodents and monkeys

Jordi Bonaventura, Mark A. G. Eldridge, Feng Hu et al. · Nature Communications · 2019 · 209 citations · Full text

Depression, anxiety, and tobacco use: Overlapping impediments to sleep in a national sample of college students

Matthew A. Boehm, Quinmill M Lei, Robin M. Lloyd et al. · Journal of American College Health · 2016 · 75 citations

Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders

Patrick H. Roseboom, Sascha A. L. Mueller, Jonathan A. Oler et al. · Molecular Therapy · 2021 · 40 citations · Full text

DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates

Sascha A. L. Mueller, Jonathan A. Oler, Patrick H. Roseboom et al. · Current Research in Neurobiology · 2023 · 11 citations · Full text

Rows per page

1–5 of 6